Statement about Media Articles as to Takeda's Acquisition of a Swiss Company

Osaka, Japan, May 13, 2011 --- Takeda Pharmaceutical Company Limited ("Takeda") has and always will comply with the rules governing the publication of any event of material significance to our business and our shareholders. The company would like to make clear that Takeda has not agreed to any such an agreement as suggested by certain newspaper publications. In addition, Takeda has a policy of not commenting on any rumors regarding our business.

Takeda is constantly seeking and evaluating opportunities to increase shareholder value and enhance our business through strategic investment, however, there is nothing that needs to be announced at this point.

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.